DK1517682T3 - Farmaceutisk formulering indeholdende en ikke-peptidisk renininhibitor og et overfladeaktivt stof - Google Patents
Farmaceutisk formulering indeholdende en ikke-peptidisk renininhibitor og et overfladeaktivt stofInfo
- Publication number
- DK1517682T3 DK1517682T3 DK03761592T DK03761592T DK1517682T3 DK 1517682 T3 DK1517682 T3 DK 1517682T3 DK 03761592 T DK03761592 T DK 03761592T DK 03761592 T DK03761592 T DK 03761592T DK 1517682 T3 DK1517682 T3 DK 1517682T3
- Authority
- DK
- Denmark
- Prior art keywords
- renin inhibitor
- surfactant
- pharmaceutical formulation
- formulation containing
- physiologically tolerated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH11242002 | 2002-06-28 | ||
PCT/EP2003/050266 WO2004002466A1 (en) | 2002-06-28 | 2003-06-25 | Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1517682T3 true DK1517682T3 (da) | 2007-02-26 |
Family
ID=29783980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03761592T DK1517682T3 (da) | 2002-06-28 | 2003-06-25 | Farmaceutisk formulering indeholdende en ikke-peptidisk renininhibitor og et overfladeaktivt stof |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050147629A1 (ja) |
EP (1) | EP1517682B1 (ja) |
JP (1) | JP4519640B2 (ja) |
AT (1) | ATE344026T1 (ja) |
AU (1) | AU2003255527A1 (ja) |
CY (1) | CY1105934T1 (ja) |
DE (1) | DE60309472T2 (ja) |
DK (1) | DK1517682T3 (ja) |
ES (1) | ES2276110T3 (ja) |
PT (1) | PT1517682E (ja) |
WO (1) | WO2004002466A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200900399A (en) * | 2003-10-01 | 2009-01-01 | Speedel Experimenta Ag | Organic compounds |
WO2005070871A2 (en) * | 2004-01-23 | 2005-08-04 | Speedel Experimenta Ag | Amino alcohol derivatives and their activity as renin inhibitors |
WO2005070877A1 (en) * | 2004-01-23 | 2005-08-04 | Speedel Experimenta Ag | Diamino alcohols and their use as renin inhibitors |
MY148773A (en) * | 2004-03-17 | 2013-05-31 | Novartis Ag | Galenic formulations of organic compounds |
US20070191487A1 (en) * | 2004-03-17 | 2007-08-16 | Rigassi-Dietrich Petra G | Galenic formulations of organic compounds |
AR050043A1 (es) * | 2004-08-03 | 2006-09-20 | Novartis Ag | Metodos para mejorar la biodisponibilidad y composicion farmaceutica para trastornos cardiovasculares |
EP1707202A1 (de) * | 2005-03-31 | 2006-10-04 | Speedel Experimenta AG | Organische Verbindungen |
EP2062874B1 (en) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Process and intermediates for the preparation of aliskiren |
EP2143425A1 (de) | 2008-07-11 | 2010-01-13 | Ratiopharm GmbH | Direktverpresste Aliskiren-Tabletten |
EP2189442B1 (en) | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process and intermediates for the preparation of aliskiren |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0031603A1 (en) * | 1979-12-31 | 1981-07-08 | American Cyanamid Company | Pharmaceutical composition of matter |
IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
US5523289A (en) * | 1991-04-15 | 1996-06-04 | Abbott Laboratories | Pharmaceutical composition |
US5326776A (en) * | 1992-03-02 | 1994-07-05 | Abbott Laboratories | Angiotensin II receptor antagonists |
ES2154277T3 (es) * | 1993-07-15 | 2001-04-01 | Hoffmann La Roche | Combinacion farmaceutica que contiene un inhibidor del sistema renina-angiotensina y un antagonista de endotelina. |
SE9503143D0 (sv) * | 1995-09-12 | 1995-09-12 | Astra Ab | New preparation |
TW426516B (en) * | 1996-12-06 | 2001-03-21 | Fujisawa Pharmaceutical Co | An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
-
2003
- 2003-06-25 AU AU2003255527A patent/AU2003255527A1/en not_active Abandoned
- 2003-06-25 EP EP03761592A patent/EP1517682B1/en not_active Expired - Lifetime
- 2003-06-25 US US10/515,817 patent/US20050147629A1/en not_active Abandoned
- 2003-06-25 JP JP2004516786A patent/JP4519640B2/ja not_active Expired - Fee Related
- 2003-06-25 ES ES03761592T patent/ES2276110T3/es not_active Expired - Lifetime
- 2003-06-25 WO PCT/EP2003/050266 patent/WO2004002466A1/en active IP Right Grant
- 2003-06-25 PT PT03761592T patent/PT1517682E/pt unknown
- 2003-06-25 AT AT03761592T patent/ATE344026T1/de active
- 2003-06-25 DK DK03761592T patent/DK1517682T3/da active
- 2003-06-25 DE DE60309472T patent/DE60309472T2/de not_active Expired - Lifetime
-
2007
- 2007-01-17 CY CY20071100066T patent/CY1105934T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1517682E (pt) | 2007-02-28 |
DE60309472D1 (de) | 2006-12-14 |
EP1517682A1 (en) | 2005-03-30 |
WO2004002466A1 (en) | 2004-01-08 |
JP2005533816A (ja) | 2005-11-10 |
DE60309472T2 (de) | 2007-06-28 |
CY1105934T1 (el) | 2011-04-06 |
ATE344026T1 (de) | 2006-11-15 |
EP1517682B1 (en) | 2006-11-02 |
ES2276110T3 (es) | 2007-06-16 |
US20050147629A1 (en) | 2005-07-07 |
AU2003255527A1 (en) | 2004-01-19 |
JP4519640B2 (ja) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105934T1 (el) | Φαρμακευτικη συνθεση που αποτελειται απο αναστολεα πενινης μη πεπτιδιου και επιφανειοδραστικο παραγοντα | |
CY1120138T1 (el) | Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv | |
YU39800A (sh) | Derivati sulfonamida kao pro-lekovi inhibitora aspartil proteaze | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
DE60117289D1 (de) | Schnelllösliche tabletten | |
CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
DK1708686T3 (da) | Generelt lineær effervescent oral fentanyldoseringsform og fremgangsmåder til indgivelse | |
RS51756B (sr) | Čvrste farmaceutske formulacije koje sadrže telmisartan | |
MY136406A (en) | High drug load tablet | |
YU69603A (sh) | Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum | |
PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
BR0209020A (pt) | Composição farmacêutica de polialilamina | |
CY1105237T1 (el) | Βελτιωμεναι φαρμακευτικαι διαμορφωσεις πepιλαμβανουσαι ritonavir | |
ATE516016T1 (de) | Selbstemulgierende formulierungen von cetp- hemmern | |
EE05423B1 (et) | IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon | |
MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
DE60323765D1 (de) | Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
NO20034863L (no) | Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser | |
DK1407763T3 (da) | Sammensætninger indeholdende en kosmetisk aktiv organisk syre og et bælgplanteprodukt | |
RS11104A (en) | Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof | |
DE50105710D1 (de) | Pharmazeutische, ramipril enthaltende brauseformulierung | |
SE0001916D0 (sv) | Novel formulation | |
BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
BG66112B1 (bg) | Подобрени фармацевтични състави |